Low molecular weight iron in cerebral ischemic acidosis in vivo

Stroke

Volumn 29, Issue 2, 1998, Pages 487-493

  Lipscomb, Diane C ^a   Gorman, Linda G ^a   Traystman, Richard J ^a   Hurn, Patricia D ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Acidosis; Cerebral ischemia; Iron; Spectroscopy, nuclear magnetic resonance

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; IRON;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DOG; HYPERGLYCEMIA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0031934177     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.2.487     Document Type: Article

References (32)

1. Braughler JM, Duncan LA, Chase RL. The involvement of iron in lipid peroxidation. J Biol Chem. 1986;22:10282-10289.
2. Halliwell B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys. 1986;246:501-514.
3. Gutteridge JMC. Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann N Y Acad Sci. 1994;739:201-213.
4. Beckman JS, Ischiropoulos H, Zhu L, van der Woerd M, Smith C, Chen J, Harrison J, Martin JC, Tsai M. Kinetics of superoxide dismutase and iron catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys. 1992;298:438-445.
5. 2. J Cereb Blood Flow Metab. 1989;9:65-70.
6. Aisen P. The transferrin receptor and the release of iron from transferrin. Adv Exp Med Biol. 1994;356:31-40.
7. Bralet J, Schreiber L, Bouvier C. Effect of acidosis and anoxia on iron delocalization from brain homogenates. Biochem Biophys. 1992;43: 979-983.
8. Bralet J, Bouvier C, Schreiber L, Boquillon M. Effect of acidosis on lipid peroxidation in brain slices. Brain Res. 1991;539:175-177.
9. Hurn PD, Koehler RC, Norris SE, Blizzard KK, Traystman RJ. Dependence of cerebral energy phosphate and evoked potential recovery on end-ischemic pH. Am J Physiol. 1991;260:H532-H541.
10. Hurn PD, Koehler RC, Blizzard KK, Traystman RJ. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke. 1995;26:688-695.
11. Kim H, Koehler RC, Hurn PD, Hall ED, Traystman RJ. Amelioration of impaired cerebral metabolism after severe acidosis ischemia by tirilazad posttreatment in dogs. Stroke. 1996;27:114-121.
12. Hurn PD, Koehler RC, Norris SE, Schwentker AE, Traystman RJ. Bicarbonate conservation during incomplete cerebral ischemia with super-imposed hypercapnia. Am J Physiol. 1991;261:H853-H859.
13. 31P magnetic resonance spectroscopy. Neurology. 1985;35:781-788.
14. Fish WW. Rapid colorimetric micromethod for the qualification of complexed iron in biological samples. In: Methods in Enzymology, vol 158. New York, NY: Academic Press; 1984:357-364.
15. Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz MA. Oxygen radicals in cerebral ischemia. Am J Physiol. 1992;263: H1356-H1362.
16. Halliwell B. Protection against tissue damage in vivo by desferoxamine: what is its mechanism of action? Free Radic Biol Med. 1989;27:595-611.
17. Hall ED, Yonkers PA, McCall JM, Braughler JM. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg. 1988;68:456-461.
18. Krause GS, Joyce KM, Nayini NR, Zonia CL, Garritano AM, Hoehner TJ, Evans AT, Indreri RJ, Huang RR, Aust SD, White BC. Cardiac arrest and resuscitation: brain iron delocalization during reperfusion. Ann Emerg Med. 1985;14:1027-1043.
19. Krause GS, Nayini NR, White BC, Hoehner TJ, Garritano AM, O'Neil BJ, Aust SD. Natural course of iron delocalization and lipid peroxidation during the first eight hours following a 15-minute cardiac arrest in dogs. Ann Emerg Med. 1987;16:1200-1205.
20. Komara JS, Nayini NR, Bialick HA, Indrieri RJ, Evans AT, Garritano AM, Hoehner TJ, Jacobs WA, Huang RR, Krause GS, White BC, Aust SD. Brain iron delocalization and lipid peroxidation following cardiac arrest. Ann Emerg Med. 1986;15:384-389.
21. Connor JR, Menzies SL, St Martin S, Muffson EJ. The cellular distribution of transferrin, ferritin, and iron in the human brain. J Neurosci Res. 1990; 27:595-611.
22. Aisen P, Listowsky I. Iron transport and storage proteins. Ann Rev Biochem. 1980;49:375-393.
23. Schlabach MR, Bates GW. The synergistic binding of anions and Fe3+ by transferrin. J Biol Chem. 1975;250:2182-2188.
24. Bates GW, Schlaback MR. The nonspecific binding of Fe to transferrin the absence of synergistic anions. J Biol Chem. 1975;250:2177-2181.
25. Ginsberg MD, Welsh FA, Budd WW. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in cat. Stroke. 1980; 11:347-354.
26. Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke. 1987;18:52-58.
27. Duckrow RB, Beard DC, Brennan RW. Regional cerebral blood flow decreases during hyperglycemia. Ann Neurol. 1985;17:267-272.
28. Fujimoto S, Kawakami N, Ohara A. Nonenzymatic glycation of transferrin: decrease of iron-binding capacity and increase of oxygen radical production. Biol Pharm Bull. 1995;18:396-400.
29. Williams AM, Enns CA. A region of the C-terminal portion of the human transferrin receptor contains an asparagine-linked glycosylation site critical for receptor structure and function. J Biol Chem. 1993;268:12780-12786.
30. O'Connell MJ, Baum H, Peters TJ. Haemosiderin-like properties of free radical-modified ferritin. Biochem J. 1986;240:297-300.
31. Gutteridge JM, Hou Y. Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron. Free Radic Res Commun. 1986;2:143-151.
32. O'Connell MJ, Halliwell B, Moorhouse CP, Aruoma OL, Baum H, Peters TJ. Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Biochem J. 1986;234:724-731.